163 related articles for article (PubMed ID: 29538199)
1. Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report.
Li J; Fan X; Wang Q
Medicine (Baltimore); 2018 Mar; 97(11):e0073. PubMed ID: 29538199
[TBL] [Abstract][Full Text] [Related]
2. Pseudoaldosteronism caused by combined administration of cilostazol and glycyrrhizin.
Maeda Y; Inaba N; Aoyagi M; Tanase T; Shiigai T
Intern Med; 2008; 47(14):1345-8. PubMed ID: 18628584
[TBL] [Abstract][Full Text] [Related]
3. An Unusual Case of Licorice-Induced Hypertensive Crisis.
Ottenbacher R; Blehm J
S D Med; 2015 Aug; 68(8):346-7, 349. PubMed ID: 26380428
[TBL] [Abstract][Full Text] [Related]
4. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
Strutz F; Bramlage P; Paar WD
Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
[TBL] [Abstract][Full Text] [Related]
5. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
Rosenstock J; Rossi L; Lin CS; MacNeil D; Osbakken M
J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
[TBL] [Abstract][Full Text] [Related]
6. 'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
van Rossum TG; de Jong FH; Hop WC; Boomsma F; Schalm SW
J Gastroenterol Hepatol; 2001 Jul; 16(7):789-95. PubMed ID: 11446888
[TBL] [Abstract][Full Text] [Related]
7. Malignant hypertension and interferon-beta: a case report.
Rubin S; Lacraz A; Galantine V; Gosse P
J Hum Hypertens; 2014 May; 28(5):340-1. PubMed ID: 24067346
[No Abstract] [Full Text] [Related]
8. Twenty-Four-Hour Urine α
Liakos CI; Vyssoulis GP; Markou MI; Kafkas NV; Toutouzas KP; Tousoulis D
J Clin Hypertens (Greenwich); 2016 Oct; 18(10):1000-1006. PubMed ID: 26992096
[TBL] [Abstract][Full Text] [Related]
9. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G;
Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
[TBL] [Abstract][Full Text] [Related]
10. Irbesartan effects on renal function in patients with renal impairment and hypertension: a drug-withdrawal study.
De Rosa ML; de Cristofaro A; Rossi M; Baiano A; Cardace P; Albanese L; Vigorito C
J Cardiovasc Pharmacol; 2001 Sep; 38(3):482-9. PubMed ID: 11486253
[TBL] [Abstract][Full Text] [Related]
11. [Hypertensive emergency and urgence].
Gegenhuber A; Lenz K
Herz; 2003 Dec; 28(8):717-24. PubMed ID: 14689106
[TBL] [Abstract][Full Text] [Related]
12. Potassium chloride mixture may maintain hypokalaemia and hypertension.
Mandoe MJ; Borg R; Hansen D
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567256
[TBL] [Abstract][Full Text] [Related]
13. Irbesartan and hydrochlorothiazide association in the treatment of hypertension.
Derosa G; Ferrari I; Cicero AF
Curr Vasc Pharmacol; 2009 Apr; 7(2):120-36. PubMed ID: 19355995
[TBL] [Abstract][Full Text] [Related]
14. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
15. Is glycyrrhizin sensitivity increased in anorexia nervosa and should licorice be avoided? Case report and review of the literature.
Støving RK; Lingqvist LE; Bonde RK; Andries A; Hansen MH; Andersen M; Hørder K
Nutrition; 2011; 27(7-8):855-8. PubMed ID: 20739148
[TBL] [Abstract][Full Text] [Related]
16. Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study.
Hasebe N; Kikuchi K;
J Hypertens; 2005 Feb; 23(2):445-53. PubMed ID: 15662234
[TBL] [Abstract][Full Text] [Related]
17. AT1-receptor antagonism in hypertension: what has been learned with irbesartan?
Waeber B; Burnier M
Expert Rev Cardiovasc Ther; 2003 May; 1(1):23-33. PubMed ID: 15030294
[TBL] [Abstract][Full Text] [Related]
18. Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
Coca A; Calvo C; Sobrino J; Gómez E; López-Paz JE; Sierra C; Bragulat E; de la Sierra A
Clin Ther; 2003 Nov; 25(11):2849-64. PubMed ID: 14693309
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive emergencies.
Burris JF
Am Fam Physician; 1985 Jul; 32(1):97-109. PubMed ID: 4013967
[TBL] [Abstract][Full Text] [Related]
20. [Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving HH; Lehnert H; Brøchner-Mortensen J; Gomis R; Andersen S; Arner P
Ugeskr Laeger; 2001 Oct; 163(40):5519-24. PubMed ID: 11601118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
